Paradigm Asset Management’s SYNAGEVA BIOPHARMA CORP COM STK (DE) GEVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2015
Q1
Sell
-5,400
Closed -$501K 883
2014
Q4
$501K Sell
5,400
-27,800
-84% -$2.58M 0.06% 307
2014
Q3
$2.28M Buy
+33,200
New +$2.28M 0.32% 103